These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3839990)

  • 1. Endogenous digoxin-like material in patients with liver disease.
    Shilo L; Shapiro MS; Dolev S; Shenkman L
    Ann Intern Med; 1985 Oct; 103(4):643. PubMed ID: 3839990
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin-like substance(s) interfere(s) with serum estimations of the drug in cirrhotic patients.
    Nikou GC; Vyssoulis GP; Venetikou MS; Karga HI; Karoutsos KA; Toutouzas PK
    J Clin Gastroenterol; 1989 Aug; 11(4):430-3. PubMed ID: 2547866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum endogenous digoxin-like substances in cirrhotic patients treated by ultrafiltration of ascites and reinfusion].
    Yang J
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):329-30. PubMed ID: 1667498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin].
    Baz MJ; Vargas F; Haro JM; Castillo MA; Jódar E; Andrade JL; García del Río C
    Rev Esp Fisiol; 1990 Dec; 46(4):385-91. PubMed ID: 2099536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digoxin-like material in liver disease].
    Shilo L; Shapiro MS; Shenkman L
    Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like immunoreactivity in human body fluids.
    Clerico A; Del Chicca MG; Montereggi A; Balzan S; Ghione S
    J Nucl Med Allied Sci; 1985; 29(4):305-12. PubMed ID: 3012031
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin-like immunoreactivity in saliva and plasma of pregnant women.
    Jakobi P; Krivoy N; Schwartz K; Ben Aryeh H; Laufer D
    Clin Chem; 1991 Jan; 37(1):135-6. PubMed ID: 1988202
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of storage temperature on concentrations of digoxin-like immunoreactive factor(s) in plasma.
    Krivoy N; Jakobi P
    Clin Chem; 1989 May; 35(5):895-6. PubMed ID: 2720993
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous digoxin-like immunoreactivity measured in seminal fluid from a normal male population.
    Vadazs A; Jakobi P; Stoler J; Makler A; Krivoy N
    Gynecol Obstet Invest; 1992; 33(4):236-8. PubMed ID: 1324208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous digoxin-like immunoreactivity in follicular fluid and in vitro fertilization.
    Jakobi P; Krivoy N; Eibschitz I; Ziskind G
    Gynecol Obstet Invest; 1991; 32(4):193-5. PubMed ID: 1663910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous digoxin-like substance(s) and combined hepatic and renal failure.
    Gault MH; Vasdev SC; Longerich LL
    Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurohumoral activity in liver cirrhosis].
    Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
    Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
    Avendaño C; Alvarez JS; Sacristan JA; Adin J; Alsar MJ
    Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antidopaminergic drugs on endogenous digoxin-like factor in psychiatric patients.
    Adawi A; Shilo L; Levy A; Neumann M; Shenkman L
    Isr J Med Sci; 1993 Aug; 29(8):466-8. PubMed ID: 8104913
    [No Abstract]   [Full Text] [Related]  

  • 20. Existence of a digitalis-like compound in the human fetus.
    Guédeney X; Chanez C; Scherrmann JM
    Biol Neonate; 1991; 59(3):133-8. PubMed ID: 1647221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.